Skip to main content
Clinical Trials/NCT01012570
NCT01012570
Terminated
Not Applicable

The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

Gerhard Rogler0 sites34 target enrollmentStarted: August 2009Last updated:

Overview

Phase
Not Applicable
Status
Terminated
Enrollment
34

Overview

Brief Summary

The investigators will study the effect of Adalimumab on the bone microstructure.

  • Trial with medicinal product

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Gerhard Rogler

Prof.Dr.Dr. gerhard Rogler

University of Zurich

Similar Trials